Hemophilia A - 29 Studies Found Completed : Phase 3/4 Study of a Recombinant Protein-Free Factor VIII (rAHF-PFM): Comparison of Continuous Infusion Versus Intermittent Bolus Infusion in Hemophilia A Subjects Undergoing Major Orthopedic Surgery : Hemophilia A : 2006-07-25 : Drug: Recombinant Protein-Free Factor VIII (rAHF-PFM) Completed : Study Evaluating B-Domain Deleted Recombinant Factor VIII (BDDrFVIII, ReFacto AF) in Patients With Hemophilia A Undergoing Elective Major Surgery : Hemophilia A : 2005-10-20 : Biological: ReFacto AF Recruiting : A Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants Without Inhibitors : Hemophilia A : 2016-07-26 : Drug: Emicizumab Participants will receive emicizumab prophylaxis at the specified dose subcutaneously u Completed : Efficacy and Safety of Recombinant Factor VIII (GreenGene) in Patients With Hemophilia A : Hemophilia A : 2012-03-22 : Drug: GreenGene Dose : 10 ~ 50IU/kg Administration method : intravenous infusion or bolus Enrolling by invitation : Platelet Function in Patients With Hemophilia A : Hemophilia A : 2014-03-19 Completed : Study of Pharmacokinetics, Efficacy and Safety of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients - A Continuation of Clinical Study 069901 : Hemophilia A : 2005-09-08 : Drug: Antihemophilic factor, recombinant, manufactured protein-free Completed : Efficacy and Safety Study of a Recombinant Protein-Free Manufactured Factor VIII (rAHF-PFM) in Previously Untreated Hemophilia A Patients : Hemophilia A : 2005-09-09 : Biological: Recombinant Antihemophilic Factor Manufactured and Formulated without Added Human or Animal Proteins (rAHF-PFM) Completed : Efficacy and Cost Effectiveness of Pharmacokinetic Dosing in Haemophilia A : Severe Haemophilia A : 2016-02-18 : Drug: Pharmacokinetic based dosage change Pharmacokinetic based dosing of factor VIII prophylaxis treatm Completed : Pharmacokinetics, Efficacy and Safety Study of IMMUNATE SD (Human Plasma-Derived Coagulation Factor VIII Concentrate) in Hemophilia A Patients : Hemophilia A : 2005-09-08 : Drug: Human Plasma-Derived Coagulation Factor VIII Concentrate (Virus Inactivated by Polysorbate 80 Treatment and Vapor Heat Treatment) Completed : Study of Pharmacokinetics, Efficacy, and Safety of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients With Hemophilia A : Hemophilia A : 2005-09-08 : Drug: Antihemophilic factor, recombinant, manufactured protein-free Next >>>
